Five research posters presented at AMCP Nexus 2025 - Prime Therapeutics
        Research & Publications
       
       Five research posters presented at AMCP Nexus 2025
Studies on GLP-1 drugs, specialty therapies and more help improve affordability in health care
 
       About Prime Therapeutics
 
         Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn.
